WallStreetZenWallStreetZen

NASDAQ: NVCT
Nuvectis Pharma Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their NVCT stock forecasts and price targets.

Forecast return on equity

Is NVCT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is NVCT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NVCT revenue forecast

What is NVCT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$62.9M
Avg 2 year Forecast
$148.5M
Avg 3 year Forecast
$202.6M

NVCT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NVCT$8.34N/AN/A
ARMP$4.10$7.00+70.73%Buy
CTMX$2.19$3.13+42.69%Hold
CLLS$2.67$6.00+124.72%Buy
DBVT$0.77$10.00+1,203.78%Buy

Nuvectis Pharma Stock Forecast FAQ

What is NVCT's revenue growth forecast for 2027-2029?

(NASDAQ: NVCT) Nuvectis Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Nuvectis Pharma's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NVCT's revenue for 2027 to be $1,117,836,718, with the lowest NVCT revenue forecast at $1,117,836,718, and the highest NVCT revenue forecast at $1,117,836,718. On average, 1 Wall Street analysts forecast NVCT's revenue for 2028 to be $2,639,203,429, with the lowest NVCT revenue forecast at $2,639,203,429, and the highest NVCT revenue forecast at $2,639,203,429.

In 2029, NVCT is forecast to generate $3,600,496,807 in revenue, with the lowest revenue forecast at $3,600,496,807 and the highest revenue forecast at $3,600,496,807.

If you're new to stock investing, here's how to buy Nuvectis Pharma stock.

What is NVCT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NVCT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NVCT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NVCT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.